1,011
Views
9
CrossRef citations to date
0
Altmetric
KEY ADDITIONAL PAPER

Screening mammography – early detection or over-diagnosis? Contribution from Australian data

Pages 66-72 | Received 30 Jun 2014, Accepted 17 Aug 2014, Published online: 16 Sep 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

J. Hersch, J. Jansen & K. McCaffery. (2018) Decision-making about mammographic screening: pursuing informed choice. Climacteric 21:3, pages 209-213.
Read now
Robin J. Bell. (2017) What is the right dose of modern medicine?. Climacteric 20:3, pages 185-186.
Read now

Articles from other publishers (7)

Geoffrey W. Stuart, James A. Chamberlain & Luc te Marvelde. (2023) The contribution of prognostic factors to socio‐demographic inequalities in breast cancer survival in Victoria, Australia. Cancer Medicine 12:14, pages 15371-15383.
Crossref
Leah S. Kim & Donald R. Lannin. (2022) Breast Cancer Screening: Is There Room for De-escalation?. Current Breast Cancer Reports 14:4, pages 153-161.
Crossref
Thu H. N. Nguyen, Thanh T. N. Nguyen, Tran T. M. Nguyen, Le H. M. Nguyen, Luan H. Huynh, Hoang N. Phan & Hue T. Nguyen. (2022) Panels of circulating microRNAs as potential diagnostic biomarkers for breast cancer: a systematic review and meta-analysis. Breast Cancer Research and Treatment 196:1, pages 1-15.
Crossref
Minghui Li, Xuan Zou, Tiansong Xia, Tongshan Wang, Ping Liu, Xin Zhou, Shui Wang & Wei Zhu. (2019) A five‐miRNA panel in plasma was identified for breast cancer diagnosis. Cancer Medicine 8:16, pages 7006-7017.
Crossref
Bo Franzén, Masood Kamali‐Moghaddam, Andrey Alexeyenko, Thomas Hatschek, Susanne Becker, Lotta Wik, Jonas Kierkegaard, Annika Eriksson, Naveen R. Muppani, Gert Auer, Ulf Landegren & Rolf Lewensohn. (2018) A fine‐needle aspiration‐based protein signature discriminates benign from malignant breast lesions. Molecular Oncology 12:9, pages 1415-1428.
Crossref
Qiuqiong Tang, Jie Cheng, Xue Cao, Harald Surowy & Barbara Burwinkel. (2016) Blood-based DNA methylation as biomarker for breast cancer: a systematic review. Clinical Epigenetics 8:1.
Crossref
Qiuqiong Tang, Tim Holland-Letz, Alla Slynko, Katarina Cuk, Frederik Marme, Sarah Schott, Jörg Heil, Bin Qu, Michael Golatta, Melanie Bewerunge-Hudler, Christian Sutter, Harald Surowy, Barbara Wappenschmidt, Rita Schmutzler, Markus Hoth, Peter Bugert, Claus R. Bartram, Christof Sohn, Andreas Schneeweiss, Rongxi Yang & Barbara Burwinkel. (2016) DNA methylation array analysis identifies breast cancer associated RPTOR , MGRN1 and RAPSN hypomethylation in peripheral blood DNA . Oncotarget 7:39, pages 64191-64202.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.